Genomic correlates and classification of PD-L1 status in non-small cell lung cancer.

被引:0
|
作者
Liang, Feng
Liu, Sisi
Jiang, Ya
Xu, Xiuxiu
Ou, Qiuxiang
Bao, Hua
Wu, Xue
Shao, Yang
Hu, Xingsheng
机构
[1] Peoples Liberat Army Gen Hosp, Med Ctr 5, Beijing, Peoples R China
[2] Nanjing Geneseeq Technol Inc, Nanjing, Peoples R China
[3] Geneseeq Technol Inc, Translat Med Res Inst, Toronto, ON, Canada
[4] Nanjing Geneseeq Technol, Toronto, ON, Canada
[5] Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Clin Res Ctr Canc, Natl Canc Ctr, Beijing, Peoples R China
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e21578
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Clinicopathological significance of the expression of PD-L1 in non-small cell lung cancer
    Montero, M. Angeles
    Aricak, Ozan
    Kis, Lorand
    Yoshikawa, Akira
    De Petris, Luigi
    Grundberg, Oscar
    Pham, Hoa H. N.
    Roden, Anja C.
    Fukuoka, Junya
    Attanoos, Richard
    Guijarro, Ricardo
    Alarcon, Felix
    Lindstrom, Kati
    Ortiz-Villalon, Cristian
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2021, 51
  • [42] PD-L1 expression and genotype in non-small cell lung cancer (NSCLC).
    Ansen, Sascha
    Schultheis, Anne Maria
    Hellmich, Martin
    Zander, Thomas
    Brockmann, Michael
    Stoelben, Erich
    Groen, Harry J. M.
    Timens, Wim
    Buettner, Reinhard
    Thomas, Roman K.
    Perner, Sven
    Wolf, Juergen
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [43] Landscape of Biomarkers in Non-small Cell Lung Cancer Using Comprehensive Genomic Profiling and PD-L1 Immunohistochemistry
    Huang, Richard S. P.
    Severson, Eric
    Haberberger, James
    Duncan, Daniel L.
    Hemmerich, Amanda
    Edgerly, Claire
    Ferguson, N. Lynn
    Frampton, Garrett
    Owens, Clarence
    Williams, Erik
    Elvin, Julia
    Vergilio, Jo-Anne
    Killian, Jonathan Keith
    Lin, Douglas
    Morley, Samantha
    McEwan, Deborah
    Holmes, Oliver
    Danziger, Natalie
    Cohen, Michael B.
    Sathyan, Pratheesh
    McGregor, Kimberly
    Reddy, Prasanth
    Venstrom, Jeffrey
    Anhorn, Rachel
    Alexander, Brian
    Brown, Charlotte
    Ross, Jeffrey S.
    Ramkissoon, Shakti H.
    PATHOLOGY & ONCOLOGY RESEARCH, 2021, 27
  • [44] Clinical and molecular correlates of immune marker profiling and PD-L1 expression in non-small cell lung cancer
    Shi, Yunfei
    Lei, Youming
    Liu, Yinqiang
    Duan, Jin
    Zhao, Wei
    Zhang, Fujun
    Lv, Guoli
    Wu, Qian
    Wu, Mengmeng
    Yin, Jiani C.
    Shao, Yang
    CANCER RESEARCH, 2022, 82 (12)
  • [45] PD-1/PD-L1 Immune Checkpoint Blockade in Non-Small Cell Lung Cancer
    Bagley, Stephen J.
    Bauml, Joshua M.
    Langer, Corey J.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (10) : 676 - 683
  • [46] Clinical impact of 22C3 PD-L1 expression in non-small cell lung cancer.
    Okabe, Naoyuki
    Takagi, Hironori
    Suzuki, Hiroyuki
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05)
  • [47] The correlation of PD-L1 and microRNA-34a and their clinical implications in human non-small cell lung cancer.
    Hong, Ji Hyung
    Roh, Kang San
    Suh, Sung-Suk
    Lee, Sukchan
    Byun, Jae Ho
    Jung, Chan-Kwon
    Park, Jae Kil
    Kang, Jin Hyoung
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [48] Correlation between PD-L1 high-expression and EGFR variants in non-small cell lung cancer.
    Liu, Yifei
    Quan, Fei
    Chen, Siqi
    Lu, Guanghua
    Yang, Yuan
    Deng, Wanglong
    Ding, Ran
    Bu, Fanfeng
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [49] Molecular regulatory network of PD-1/PD-L1 in non-small cell lung cancer
    Zhu, Lingling
    Lin, Jiewei
    Wang, Li
    Yan, Danli
    Zhou, Jie
    Li, Wen
    Pu, Dan
    Peng, Lei
    Zhou, Qinghua
    PATHOLOGY RESEARCH AND PRACTICE, 2020, 216 (04)
  • [50] Biomarkers predictive of PD1/PD-L1 immunotheraphy in non-small cell lung cancer
    Lupo, A.
    Alifano, M.
    Wislez, M.
    Boulle, G.
    Velut, Y.
    Biton, J.
    Cremer, I.
    Goldwasser, F.
    Leroy, K.
    Damotte, D.
    REVUE DE PNEUMOLOGIE CLINIQUE, 2018, 74 (05) : 339 - 350